T cells key in atherosclerosis-linked inflammation

August 22, 2012 in Medical research

T cells key in atherosclerosis-linked inflammation

In a mouse model of atherosclerosis, CD4+ T cells interact with antigen-presenting cells in the presence of cognate antigen, leading to cell activation and proliferation and the secretion of proinflammatory cytokines, according to an experimental study published online Aug. 13 in the Journal of Clinical Investigation.

(HealthDay) -- In a mouse model of atherosclerosis, CD4+ T cells interact with antigen-presenting cells (APCs) in the presence of cognate antigen, leading to cell activation and proliferation and the secretion of proinflammatory cytokines, according to an experimental study published online Aug. 13 in the Journal of Clinical Investigation.

Ekaterina K. Koltsova, M.D., Ph.D., of the La Jolla Institute for Allergy and Immunology in California, and colleagues compared the behavior and role of APCs in normal and atherosclerotic mice using live- of explanted aortas.

The researchers found that, in the presence, but not the absence, of cognate antigen, CD4+ T cells were able to interact with fluorescently labeled APCs in the aortic wall. In atherosclerosis-prone mice, APCs interacted with CD4+ T cells in the aorta, which resulted in cell activation and proliferation and the secretion of cytokines (interferon-γ and tumor necrosis factor-α). Uptake of oxidized and minimally modified low-density lipoproteins was enhanced by these cytokines.

"We conclude that antigen presentation by APCs to CD4+ T cells in the arterial wall causes local T-cell activation and production of proinflammatory cytokines, which promote atherosclerosis by maintaining chronic inflammation and inducing foam cell formation," the authors write.

More information: Abstract
Full Text

Journal reference: Journal of Clinical Investigation search and more info website

Copyright © 2012 HealthDay. All rights reserved.

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Now we know why old scizophrenia medicine works on antibiotics-resistant bacteria

In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as ...

Medical research created May 17, 2013 | popularity 3.7 / 5 (3) | comments 0 | with audio podcast

SUMO wrestling cells reveal new protective mechanism target for stroke

Scientists investigating the interaction of a group of proteins in the brain responsible for protecting nerve cells from damage have identified a new target that could increase cell survival.

Medical research created May 17, 2013 | popularity 5 / 5 (1) | comments 0

How serotonin receptors can shape drug effects, from LSD to migraine medication

New findings by researchers carrying out experiments at the U.S. Department of Energy Office of Science's Advanced Photon Source (APS) help explain why some drugs that interact with two kinds of human serotonin ...

Medical research created May 17, 2013 | popularity not rated yet | comments 0 | with audio podcast

Preventing blood poisoning

Peptide molecules derived from the body's natural immune system can help boost the body's defence against life-threatening blood poisoning, joint University research has uncovered.

Medical research created May 17, 2013 | popularity 4 / 5 (1) | comments 0 | with audio podcast

New mechanism to prevent type 2 diabetes in obese individuals

A new Montréal study conducted by Dr. May Faraj, associate research professor at the Université de Montréal and invited scientist at the IRCM, along with her research team and medical collaborators, shows ...

Medical research created May 17, 2013 | popularity not rated yet | comments 0 | with audio podcast


Ketamine shows significant therapeutic benefit in people with treatment-resistant depression

Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...

Consuming coffee linked to lower risk of detrimental liver disease, study finds

Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...

Research examines new methods for managing digestive health

Research presented at Digestive Disease Week (DDW) explores new methods for managing digestive health through diet and lifestyle.

New research identifies risks, interventions for children's GI health

An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week (DDW).

New smartphone application improves colonoscopy preparation

The use of a smartphone application significantly improves patients' preparation for a colonoscopy, according to new research presented today at Digestive Disease Week (DDW). The preparation process, which begins days in ...

New research identifies practice changes to improve value and quality of GI procedures

There are significant cost and risk factors associated with two procedures commonly used to diagnose or treat gastrointestinal problems, according to research presented at Digestive Disease Week (DDW).